Vol. 111, No. 3, 1983 March
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
29, 1983
Pages
958-963
PRESENCE OF VIP RECEPTORS IN A HUMAN PANCREATIC ADENOCARCINOMA CELL LINE. MODULATION OF THE CAMP RESPONSE DURING CELL PROLIFERATION A. Estival,
P. Mounielou, V. Trocheris, J.L. Scemama, F. Clemente, E. Hollande and A. Ribet
INSERM U 151, Received
February
CHU Rangueil
Bat L3 - 31054
Toulouse,
France
7, 1983
It is known that the human exocrine pancreas responds to secretin stimulation more than does VIP, a structurally related peptide. We looked for the receptors for those polypeptides in a human pancreatic cancer cell line.grown in culture and in nude mice. By analysing the CAMP responses and the I25IVIP binding we found VIP receptors with a KD of 1.5 10-g M. Secretin stimulates the adenylate cyclase through the VIP receptor sites with a KD of 1.7. 10-6 M. We noted also that during cell proliferation in culture there was about a 5 fold increase of the CAMP response to VIP. It is known that pancreas
in
regulating
proliferation of the
creatic
the
to induce
pancreas cells
(2).
of
the hormone
cancer
may permit cells.
cyclic
nucleotide
We analyse
established
known for
of the cyclase
(Swiss
juice
secretion
In spite
cancer
which
is
the
wether
regulation
with
of the growth new suited
showed
that
cause
on the
pan-
human or animal. and the differen-
ways of action secretin
responses
in an adenocarcinoma
paper
VIP receptors
the
cell
frequency
the fourth
hormones
dealing
one to find
but also
increasing
presently
gastrointestinal
We previously
in this
of
on the exocrine
on
and CCK are of the
human
on the same cancer
in culture.
The results data
may act
(1).
analysed
cancer
hormones
the pancreatic
of the
has been poorly
of this
pancreatic
able
only
the action
knowledge
tiation
not
pancreatic
by cancer, cancer
A better
gastrointestinal
and differentiation
human exocrine
of death
the
the
obtained normal
response
show important human pancreas
in cultured
differences and,
cells
after
furthermore
by comparison
show a modulation
plating.
MATERIALS AND METHODS A human pancreatic adenocarcinoma was heterotransplanted strain nu+/nu+) and after 15 passages from nude to nude,
0006-291X/83 $1.50 Copyright 0 1983 by Academic Press, Inc. All rights of reproduction in any form reserved.
958
to the
in nude mice established
BIOCHEMICAL
Vol. 111, No. 3, 1983
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
in culture (3). Cultured cells were grown in 25 cm2 Nunc flaskHam’s FI2 (Gibco) medium supplemented with 10 % foetal calf serum (Gibco) penicillin G (60 pg/ml) streptomycin (100 rig/ml) and amphotericin B (0.25 pg/ml), at 37"C, in moist air containing 5 % ~02. Medium was changed every 48 hours and the cells were subcultured weekly by EDTA treatment (0.02 %). This cell line has a doubling time of 36 hs, is tumorigen in nude mice, and does not synthesize the secretory enzymes normally exported by acinar cells. For current experiments cells were harvested 8-10 days after plating. Before each experiment culture flasks were incubated 5 min in Ham's F12 medium containing 0.02 % EDTA. Cells were then mildly harvested with a rubber policeman. Detachement with 0.1 % trypsin or collagenase leads to lower CAMP responses and higher Cells were isolated from the tumors forEDTA concentrations were unnecessary. med in nude mice as previously described (2) ; the only modification was the replacement of collagenase by EDTA (0.02 %). In brief, tumor slices were incubated 15 min in Ham's F12 medium containing EDTA in a shaking bath (120 revolution/min). The medium was then filtered through 250 n nylon mesh and centrifuged 15 min at 19 gmax on a discontinuous gradient of albumin, to separate the cancer cells from the few macrophages present in tumor. Cell viability tested by the ability to exclude trypan blue was 90 %. 1251 labelled porcine VIP was prepared by the chloramine-T technique and the radiolabelled hormone isolated by high pressure liquid chromatography on Bondapak CI8 columns (Waters) using as solvent : 0.25 M triethylamine phosphate and a step gradient of acetonitrile 28-50 %, pH 3.4. The specific activity of I25VIP was about 900 Ci/mmole. Labelled I25I-VIP was shown to stimulate the enzyme secretion from guinea pig pancreatic acini as the native hormone. Binding studies were performed by incubating the isolated cells in F12 medium complemented with 1 % albumin (fraction V Sigma), antibiotics and 25 mM Hepes, pH 7.4 at 25“ C with I25I-VIP, the incubation mixture (300 ~1) contained about 30,000 cpm and 2.105 cells in the presence or absence of unlabelled VIP or secretin (Hoffman La Roche). At the end of incubations the unbound hormone was eliminated by centrifugating 200 ul cells through I ml medium containing 4 % albumin at 4" C. Pellets were counted for radioactivity in a gamma counter. The nonspecific binding (at 10-6 M VIP) was lower than I8 % of the total binding ( -3000 cpm/2.105 cells). To examine the CAMP response at 25"C, cells were preincubated I5 min in F12 medium containing I % albumin and 5 r&l theophylline (2). The hormone was then added and the incubation stopped 30 minutes later with cold methanol (4). The plateau value of the CAMP response was reached lo-15 minute after the hormone addition and remained stable for at least60 min. After centrifugation the supernatant was collected, methanol eliminated by lyophilisation and the CAMP measured by radioimunoassay (HEN). Each experiment was performed in triplicate and repeated at least three times. RESULTS a) Characterization Fig.
1 reports
cultured
cells
maximal
response
which
is
nucleotide
of the
the dose-response
after
stimulation
to VIP is
a gastrointestinal response
maxima1
response
response
curves
only
obtained
at high
obtained
curves
with
2.1O'g
the
CAMP accumulation
structurally
with cells
10-5
959
Secretin,
analogue
to VIP,
starting
from
M secretin.
isolated
from
in
at 25" C. The half-
M concentration.
concentrations,
reached with
for
VIP and secretin, with
hormone
is not yet were
VIP receptors.
10-8
Identical the
tumor
evokes
a
M. The dose-
grown
in
Vol. 111, No. 3, 1983
01
BIOCHEMICALAND BIOPHYSICAL RESEARCHCOMMUNICATIONS
11 10 9 8 7 _ Log M
6
0r2
5
12 11 10 9
8
7 6
,LogM
w-
* Effect of VIP and secretin on CAMP accumulation in cultured cells. arves ed cells were incubated for 30 min at 25'C in the presence of theophylline (5 mM) and VIP or secretin. Values from three separete experiments, each one performed in triplicate.
: Competitive inhibition of 1251-VIP binding to cultured cells by iiF an secretin. Cells were incubated for 45 min at 25°C in the presence of 125I-VIP and increasing concentrations of VIP and secretin. Results are expressed as the percentage of radioactivity specifically bound in absence of unlabelled peptide. All values are means of 4 separate experiments each one performed in triplicate.
nude mice, with
from which
cultured
obtained binding
cells
well
with
VIP competes inhibition for
is
very
to the 1.7.
During were
variable.
the
plateau
Binding
requirements
binding
values
1.2.
1). Fig.
for
10-g M VIP, 2 also
properly
a value
reports
For secretin
by secretin.
by the measure
performed
and reversibility
1251-VIP (Fig.
of
studies
125 I-VIP binding of
The saturability
one obtained
10-6
b) Modulations
the with
(Fig,
provoked
KD is
the basic
obtained
VIP binding
the
incubation.
with
CAMP formation
closed
was established.
at 25°C show that
a 1 hour
after fit
the culture
the also,
speak
2),
are of this
of receptors.
and the
half-maximal
comparable
to that
found
inhibition
of the
1251-
the competition
curve
of the CAMP accumulation,
is where
M. of the
course
We then
cyclic
of these looked
for
nucleotide studies
response
we noted
the responsible
960
that
maximal
parameters
CAMP responses and observed
5
BIOCHEMICAL
Vol. 111, No. 3, 1983
Table
AND BIOPHYSICAL
I : CAMP modulation CAMP
during
pmoles/106
growth.
cells
Stimulated
6
days
38.41 (S/B
15 days
that
VIP stimulations plating
(Table
after
plating,
the
levels
as high
(Table
I) there This
either
the
is
increasing
CAMP accumulation those
of the
kinetics
is very
6 days
in the nucleotide
; this
of a new type
Stimulations the presence
responses
basal
fact
the days
since
15 days
to basal
ratios)
reaches
In the same time
plating.
concentration
increase
does
during
important
after
is
of the CAMP accumulation
VIP and secretin
+ 0.96
(stimulated
found
no difference
modulation
appearance
M) evoke
4.18
basal ratios. 10-T M VIP in (n = 6).
Such an increase
as 5 times
of the
ves for
I).
3.80 t 1.27
212 t 12.50 (S/B : 50)
(10-T
after
Basal
t 11.90 f 10)
to S/B : stimulated were performed with of 5 mM theophylline
RESEARCH COMMUNICATIONS
of CAMP.
unrelated
or of the
not agree
with
to modifications dose-response
the
cur-
hypothesis
of
of receptor.
DISCUSSION Detailed
available
from
agonist
"in for
mal secretory secretin
event
if
viva"
response
and
moreover
the
responses
are qualitatively
data
lead
one to believe
from
the
it
is
cells
provoked
identical that
human pancreatic
(5)
lower
only
by
polypeptides : secretion VIP interacts adenocarcinoma 961
than
which
doses
not
show that
analysed
VIP is a
obtained
with
of
In
VIP.
receptors. here,
any
identical,
and bicarbonate.
secretin
are
The maxi-
quantitatively
of water with
Some data
to secretin.
that
higher
are
a structural
lacking.
in comparison
by VIP is
to both
are
investigations secretion
evoked
VIP and secretin,
for
pancreatic
clinical
the pancreatic
they
issued
on the receptors
of VIP, on human normal
analogue
poor
studies
resoond
These Cells to
Vol. 111, No. 3, 1983
VIP and secretin higher
; the binding
affinity
These
for
affinity
Or cancer favour
the
are
possessing
hypothesis
the dose-response
for
concentrations (6).
1 nM (8-9).
Besides,
cases
the
sites
explored
CAMP accumulation
after
there
are
red.
Preliminary
should
us to find
results
are
finding
of identical
not
disagrees
with
of cells
lacking
report
on the
results
an isolated
secretin presence
another lead
curves
during
of VIP receptors
for
VIP.
with
cells
knowledge,
in pancreatic
to that
in both
Moreover
maximal
doses
not
the
of VIP
additive
but
It seems then,
shown).
cell
line
explo-
cancer
one to think to that
To our
corresponds
cancer
the establishment
receptors.
secretin-receptor
human pancreatic
peculiar
dose-response
not
pancreatic
that
finding
selection
(data
unphysiological
have a KD of about
(10m6 M) is
in the
high
since
and therefore
with
do not
receptors
secretin
to those
stimulation
with
at
M.
human normal
Our results
secretin
by secretin
VIP alone
obtained
identical
the
(6,7).
for
dose of secretin
VIP receptors
in other
generally
curve
have a
: KD 1.7 10-6
non specific
receptors
correspond
with
found
begins
for
hormones
secretin
of specific
found
a combined
results
allowed
existence
of 12SI-VIP
obtained
only
for
to those
RESEARCH COMMUNICATIONS
these
VIP receptors
dose-response
M) and a non maximal
that
M than
close
secretin
the
the displacement
the values
very
lo-'
with
the CAMP formation
Specific
for
equals
explored
as generally
found
(lo-7
sites
specific
of the
curve
interactions
AND BIOPHYSICAL
VIP : KD 1.2-2
constants
cells
hormone
BIOCHEMICAL
that
pancreatic
the
from
in culture is
cancer
present
cancer.
isolated
this
line
The
tumors
of a clone the first
either
in human
or in animal. The VIP receptors AMP response, that
the
lated. the
amplitude
the
et al with
VIP.
nucleotide
only
response
when cells
response
(10) showed
at least
we analysed.
nucleotide
density,
of the
functional
parameter
of the
At low cell
Morera tion
level
the
are
is
then
response
to VIP is
to the cyclic
The experimental
are growing
in the
data
inhibition
be of interest
962
of the
to know wether
a phenotypic
cell cell
show is modu-
exponential
In a mouse adrenal
lower.
only
regard
due to the VIP stimulation
a dose-dependant
It would
with
line
phase, (Y - 1)
prolifera-
the modulation
expression
during
of cell
BIOCHEMICAL
Vol. 111, No. 3, 1983
proliferation
or if
the
receptors
AND BIOPHYSICAL
for
VIP are
somehow
RESEARCH COMMUNICATIONS
involved
in cell
proli-
feration. Acknowledgments We thank iodinated
Dr L. Pradayrol
for
labelling
and purification
of the
VIP.
REFERENCES F. and Bastie, M.J. (1981) Reprod. Nutr. 1. Balas, D., Senegas-galas, Develop. 21, 783-803. F. and Ribet, A. (1981) Biochem. Biophys. Res. 2. Estival, A., Clemente, Commun. 102, 1336-1341. 3. Hollande, E. In press. 4. Rosselin, G.,Freychet, P., Fouchereau, M., Rancon, F. and Broer, Y. (1974) Hormone Metab. Res. 5, 78-86. 5. Domschke, S., Domschke, W., Rosch, W., Konturek, S.J., Sprugel, W., Mitznegg, P. and Demling, L. (1977) Gastroenterology 73, 478-480. 6. Laburthe, M., Rousset, M., Chevalier, G., Boissard, C., DuPont, C., Zweibaum, A. and Rosselin, G. (1980) Cancer Res. 40, 2529-2533. 7. DuPont, G., Broyart, J.-P., Broer, Y., Chenut, B., Laburthe, M. and Rosselin, G. (1981) J. Clin. Invest. 67, 742-752. 8. Robberecht, P., Deschodt-Lankman, M., Lammens, M., De Neef, P. and Cristophe, J. (1977) Gastroenterol. Clin. Biol. 1, 519-525. 9. Jensen, R.T. and Gardner, J.D. (1981) Federation Proc., 40, 2486-2496. 10. Morera, A.M., Cathiard, A.M., Laburthe, M. and Saez, J.M. (1979) Biochem. Biophys. Res. Corrmun. 90, 78-85.
963